EZH2 and ischemic cardiomyopathy: Although mechanistic studies are required to determine the direct role of both DNA methylation and EZH2 in heart failure, defining the epigenetic and/or metabolic machinery contribute to precision-based interventions for ischemic cardiomyopathy.